InnovAge Announces Financial Results for the Fiscal Year and Fourth Quarter Ended June 30, 2021

NEXT STORY
Rhythm Pharmaceuticals Announces Marketing Authorisation of IMCIVREE® (setmelanotide) in Great Britain
PREV STORY
Vaxcyte to Present at 2021 Cantor Virtual Global Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Affimed Reports Financial Results for Fourth Quarter and Year End 2017

Heidelberg, Germany, March 20, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical ...

author_avatar
NASDAQ Market News

II-VI Incorporated Launches Ultraviolet Fluorescence Filters for Biomedical Instruments  

PITTSBURGH, Jan. 17, 2018 (GLOBE NEWSWIRE) -- II‐VI Incorporated (NASDAQ:IIVI), a leading provider of ...

author_avatar
NASDAQ Market News

Horizon Pharma plc Names Shao-Lee Lin, M.D., Ph.D. Executive Vice President, Research and Development and Chief Scientific Officer

DUBLIN, Ireland, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical ...

author_avatar
NASDAQ Market News